跳至主要内容
临床试验/EUCTR2007-007950-77-GB
EUCTR2007-007950-77-GB进行中(未招募)1 期

Does progesterone prophylaxis to prevent preterm labour improve outcome? - a randomised double blind placebo controlled trial (OPPTIMUM) - OPPTIMUM

niversity of Edinburgh and NHS Lothian Health Board0 个研究点目标入组 1,228 人开始时间: 2008年2月8日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
1,228

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • High risk for PTB as indicated by: at least one of (i) history of previous PTB/ second trimester loss (ii) previous preterm premature rupture of the fetal membranes (iii) short cervical length (< 25mm) on ultrasound at 18 – 22 weeks gestation. Additionally all will have a positive fFN at 22weeks. All women will have gestation established by scan at =16 weeks.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Known significant structural or chromosomal fetal anomaly; known sensitivity, contraindication or intolerance to progesterone; suspected or proven rupture of the fetal membranes at the time of recruitment; multiple pregnancy; prescription or ingestion of medications known to interact with progesterone (eg ketoconazole and ciclosporin).

研究者

发起方
niversity of Edinburgh and NHS Lothian Health Board

相似试验

Does progesterone prophylaxis to prevent preterm... | 临床试验